These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21690289)

  • 1. The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor γ through spatial relocalization at helix 7 of its ligand-binding domain.
    Burgermeister E; Friedrich T; Hitkova I; Regel I; Einwächter H; Zimmermann W; Röcken C; Perren A; Wright MB; Schmid RM; Seger R; Ebert MP
    Mol Cell Biol; 2011 Aug; 31(16):3497-510. PubMed ID: 21690289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma.
    Burgermeister E; Seger R
    Cell Cycle; 2007 Jul; 6(13):1539-48. PubMed ID: 17611413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer.
    Friedrich T; Söhn M; Gutting T; Janssen KP; Behrens HM; Röcken C; Ebert MPA; Burgermeister E
    EBioMedicine; 2016 Jun; 8():159-172. PubMed ID: 27428427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
    Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
    J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of caveolin-1 in Apc(min/+) mice promotes colorectal tumorigenesis.
    Friedrich T; Richter B; Gaiser T; Weiss C; Janssen KP; Einwächter H; Schmid RM; Ebert MP; Burgermeister E
    Carcinogenesis; 2013 Sep; 34(9):2109-18. PubMed ID: 23640045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma.
    Burgermeister E; Chuderland D; Hanoch T; Meyer M; Liscovitch M; Seger R
    Mol Cell Biol; 2007 Feb; 27(3):803-17. PubMed ID: 17101779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.
    Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI
    Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
    Burgermeister E; Tencer L; Liscovitch M
    Oncogene; 2003 Jun; 22(25):3888-900. PubMed ID: 12813462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
    Yano M; Matsumura T; Senokuchi T; Ishii N; Murata Y; Taketa K; Motoshima H; Taguchi T; Sonoda K; Kukidome D; Takuwa Y; Kawada T; Brownlee M; Nishikawa T; Araki E
    Circ Res; 2007 May; 100(10):1442-51. PubMed ID: 17463321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin activates peroxisome proliferator-activated receptor γ (PPARγ) through a pathway involving PPARγ coactivator 1α (PGC1α).
    Singh S; Simpson RL; Bennett RG
    J Biol Chem; 2015 Jan; 290(2):950-9. PubMed ID: 25389293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological activation of PPARγ inhibits hypoxia-induced proliferation through a caveolin-1-targeted and -dependent mechanism in PASMCs.
    Yang K; Zhao M; Huang J; Zhang C; Zheng Q; Chen Y; Jiang H; Lu W; Wang J
    Am J Physiol Cell Physiol; 2018 Apr; 314(4):C428-C438. PubMed ID: 29351409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
    Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
    Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
    Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
    J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor γ upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer.
    Cho SJ; Kook MC; Lee JH; Shin JY; Park J; Bae YK; Choi IJ; Ryu KW; Kim YW
    Int J Cancer; 2015 Feb; 136(4):810-20. PubMed ID: 24976296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DOK1/PPARgamma pathway mediates anti-tumor ability of all-trans retinoic acid in breast cancer MCF-7 cells.
    Ding X; Wang W; Wang M; Wu J; Yao F
    Biochem Biophys Res Commun; 2017 May; 487(2):189-193. PubMed ID: 28396148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress.
    Gardner OS; Shiau CW; Chen CS; Graves LM
    J Biol Chem; 2005 Mar; 280(11):10109-18. PubMed ID: 15649892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome Proliferator-Activated Receptor γ-Mediated Inhibition on Hypoxia-Triggered Store-Operated Calcium Entry. A Caveolin-1-Dependent Mechanism.
    Yang K; Lu W; Jiang Q; Yun X; Zhao M; Jiang H; Wang J
    Am J Respir Cell Mol Biol; 2015 Dec; 53(6):882-92. PubMed ID: 26020612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
    Han S; Sidell N; Fisher PB; Roman J
    Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.
    Dawson MI; Ye M; Cao X; Farhana L; Hu QY; Zhao Y; Xu LP; Kiselyuk A; Correa RG; Yang L; Hou T; Reed JC; Itkin-Ansari P; Levine F; Sanner MF; Fontana JA; Zhang XK
    ChemMedChem; 2009 Jul; 4(7):1106-19. PubMed ID: 19378296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance.
    Tencer L; Burgermeister E; Ebert MP; Liscovitch M
    Anticancer Res; 2008; 28(2A):895-906. PubMed ID: 18507034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.